Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive adult-onset neurodegenerative disease that is often diagnosed with a delay due to initial non-specific symptoms. Therefore, reliable and easy-to-obtain biomarkers are an absolute necessity for earlier and more accurate diagnostics. Circula...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/5/1316 |
_version_ | 1797600905807265792 |
---|---|
author | Metka Ravnik Glavač Massimo Mezzavilla Ana Dolinar Blaž Koritnik Damjan Glavač |
author_facet | Metka Ravnik Glavač Massimo Mezzavilla Ana Dolinar Blaž Koritnik Damjan Glavač |
author_sort | Metka Ravnik Glavač |
collection | DOAJ |
description | Amyotrophic lateral sclerosis (ALS) is a rapidly progressive adult-onset neurodegenerative disease that is often diagnosed with a delay due to initial non-specific symptoms. Therefore, reliable and easy-to-obtain biomarkers are an absolute necessity for earlier and more accurate diagnostics. Circular RNAs (circRNAs) have already been proposed as potential biomarkers for several neurodegenerative diseases. In this study, we further investigated the usefulness of circRNAs as potential biomarkers for ALS. We first performed a microarray analysis of circRNAs on peripheral blood mononuclear cells of a subset of ALS patients and controls. Among the differently expressed circRNA by microarray analysis, we selected only the ones with a host gene that harbors the highest level of conservation and genetic constraints. This selection was based on the hypothesis that genes under selective pressure and genetic constraints could have a major role in determining a trait or disease. Then we performed a linear regression between ALS cases and controls using each circRNA as a predictor variable. With a False Discovery Rate (FDR) threshold of 0.1, only six circRNAs passed the filtering and only one of them remained statistically significant after Bonferroni correction: hsa_circ_0060762 and its host gene CSE1L. Finally, we observed a significant difference in expression levels between larger sets of patients and healthy controls for both hsa_circ_0060762 and CSE1L. CSE1L is a member of the importin β family and mediates inhibition of TDP-43 aggregation; the central pathogenicity in ALS and hsa_circ_0060762 has binding sites for several miRNAs that have been already proposed as biomarkers for ALS. In addition, receiver operating characteristics curve analysis showed diagnostic potential for CSE1L and hsa_circ_0060762. Hsa_circ_0060762 and CSE1L thus represent novel potential peripheral blood biomarkers and therapeutic targets for ALS. |
first_indexed | 2024-03-11T03:55:24Z |
format | Article |
id | doaj.art-1baca930541a416faf6acf008dfb9a11 |
institution | Directory Open Access Journal |
issn | 2227-9059 |
language | English |
last_indexed | 2024-03-11T03:55:24Z |
publishDate | 2023-04-01 |
publisher | MDPI AG |
record_format | Article |
series | Biomedicines |
spelling | doaj.art-1baca930541a416faf6acf008dfb9a112023-11-18T00:35:14ZengMDPI AGBiomedicines2227-90592023-04-01115131610.3390/biomedicines11051316Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALSMetka Ravnik Glavač0Massimo Mezzavilla1Ana Dolinar2Blaž Koritnik3Damjan Glavač4Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, SloveniaDepartment of Biology, University of Padua, 35122 Padua, ItalyDepartment of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, SloveniaInstitute of Clinical Neurophysiology, Division of Neurology, University Medical Centre Ljubljana, 1000 Ljubljana, SloveniaDepartment of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, SloveniaAmyotrophic lateral sclerosis (ALS) is a rapidly progressive adult-onset neurodegenerative disease that is often diagnosed with a delay due to initial non-specific symptoms. Therefore, reliable and easy-to-obtain biomarkers are an absolute necessity for earlier and more accurate diagnostics. Circular RNAs (circRNAs) have already been proposed as potential biomarkers for several neurodegenerative diseases. In this study, we further investigated the usefulness of circRNAs as potential biomarkers for ALS. We first performed a microarray analysis of circRNAs on peripheral blood mononuclear cells of a subset of ALS patients and controls. Among the differently expressed circRNA by microarray analysis, we selected only the ones with a host gene that harbors the highest level of conservation and genetic constraints. This selection was based on the hypothesis that genes under selective pressure and genetic constraints could have a major role in determining a trait or disease. Then we performed a linear regression between ALS cases and controls using each circRNA as a predictor variable. With a False Discovery Rate (FDR) threshold of 0.1, only six circRNAs passed the filtering and only one of them remained statistically significant after Bonferroni correction: hsa_circ_0060762 and its host gene CSE1L. Finally, we observed a significant difference in expression levels between larger sets of patients and healthy controls for both hsa_circ_0060762 and CSE1L. CSE1L is a member of the importin β family and mediates inhibition of TDP-43 aggregation; the central pathogenicity in ALS and hsa_circ_0060762 has binding sites for several miRNAs that have been already proposed as biomarkers for ALS. In addition, receiver operating characteristics curve analysis showed diagnostic potential for CSE1L and hsa_circ_0060762. Hsa_circ_0060762 and CSE1L thus represent novel potential peripheral blood biomarkers and therapeutic targets for ALS.https://www.mdpi.com/2227-9059/11/5/1316amyotrophic lateral sclerosisALScircRNAbiomarkerperipheral blood biomarkerhsa_circ_0060762 |
spellingShingle | Metka Ravnik Glavač Massimo Mezzavilla Ana Dolinar Blaž Koritnik Damjan Glavač Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS Biomedicines amyotrophic lateral sclerosis ALS circRNA biomarker peripheral blood biomarker hsa_circ_0060762 |
title | Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS |
title_full | Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS |
title_fullStr | Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS |
title_full_unstemmed | Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS |
title_short | Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS |
title_sort | aberrantly expressed hsa circ 0060762 and cse1l as potential peripheral blood biomarkers for als |
topic | amyotrophic lateral sclerosis ALS circRNA biomarker peripheral blood biomarker hsa_circ_0060762 |
url | https://www.mdpi.com/2227-9059/11/5/1316 |
work_keys_str_mv | AT metkaravnikglavac aberrantlyexpressedhsacirc0060762andcse1laspotentialperipheralbloodbiomarkersforals AT massimomezzavilla aberrantlyexpressedhsacirc0060762andcse1laspotentialperipheralbloodbiomarkersforals AT anadolinar aberrantlyexpressedhsacirc0060762andcse1laspotentialperipheralbloodbiomarkersforals AT blazkoritnik aberrantlyexpressedhsacirc0060762andcse1laspotentialperipheralbloodbiomarkersforals AT damjanglavac aberrantlyexpressedhsacirc0060762andcse1laspotentialperipheralbloodbiomarkersforals |